We propose that the S100A4-embigin/AMPK/mTORC1/p21WAF1 and NF-κB/MMP9 axis is a vital oncogenic molecular machinery exploited by a certain fraction of prostate cancers for progression. Here, EMB is linked to prostate cancer.